Abstract: An epoxy resin composition, a transparent composite material including the same, and a laminated board. The epoxy resin composition includes an epoxy resin A and an epoxy resin B. The refractive index of the epoxy resin A is 1.54-1.8 and the light transmittance of the epoxy resin A is 90%. The refractive index of the epoxy resin B is 1.54-1.8 and the light transmittance of the epoxy resin B is greater than 90%. The epoxy resin A is an organosilicon modified epoxy resin. The epoxy resin B is another type of epoxy resin. The organosilicon modified epoxy resin satisfying a specific condition and another type of epoxy resin also satisfying the specific condition are combined to form a specific epoxy resin composition. The composite material prepared from the epoxy resin composition, a curing agent, and a curing accelerator has the advantages of having high light transmittance and high bending strength, and also has high bonding strength.

Abstract: The present disclosure provides a modified resin composition, a preparation method and use thereof. The raw materials of the modified resin composition includes: 65 to 100 parts by mass of a matrix resin, 10 to 40 parts by mass of a phenoxy resin, 0.5 to 25 parts by mass of nano silicon dioxide, 2 to 15 parts by mass of a curing agent, 0 to 2 parts by mass of a curing accelerator, and 0 to 1 part by mass of a coupling agent. The modified resin composition has excellent toughness, excellent processability during mechanical punching process, a relatively low powder loss rate, and excellent bonding performance and heat resistance.

Abstract: Provided are a parthenogenetic haploid induction gene DMP and an application thereof. The parthenogenetic haploid induction genes AtDMP8 and AtDMP9 are cloned from Arabidopsis thaliana. Experiments have shown that mutations of AtDMP8 and AtDMP9 can produce parthenogenetic haploid inducibility, to enable dicotyledonous crops to be induced to produce haploids via parthenogenetic means. The present invention was further verified in tomatoes, and it was also found in tomatoes that the mutation of SlDMP can produce parthenogenetic haploid inducibility. The invention lays an important foundation for broadening the application of haploid breeding technology on dicotyledonous plants and revealing the biological mechanism of parthenogenetic haploid production. Given the universality of the utilization of haploid breeding technology in the current breeding industry, the invention has very wide application space and market prospects.

Abstract: The present invention relates to modified carbon black and a production method therefor, a resin composition and copper clad laminate. The modified carbon black comprises carbon black and a modified group; the surface of the carbon black has an acyl chloride group; the modified group is formed by a modified macromolecule and the acyl chloride group undergoing a grafting reaction; and the modified macromolecule is an alcohol macromolecule.

Abstract: The present disclosure relates to the field of early non-invasive diagnosis, and specifically, to a method of determining a virtual hepatic venous pressure gradient. The method includes: constructing a 3-dimensional (3D) hepatic vein-portal vein model; establishing a finite element division mathematical model; and applying fluid dynamics to compute and simulate a virtual hepatic venous pressure gradient (vHVPG). The method optimizes and improves a more complete 3D hepatic vein-portal vein model, finite element division, and fluid dynamic simulation computation, constructing and validating a new vHVPG determination technology providing better diagnosis, providing a safe, non-invasive, accurate, and quantitative method for early non-invasive diagnosis of a portal vein high pressure patient.

Abstract: The present invention belongs to the technical field of embryo cryopreservation. In particular, the present invention relates to an in-vitro embryonic culture medium for improving the thawed recovery rate of an embryo, comprising an inhibitor of Cathepsin L inhibitor, for example, E-64d. The present invention also relates to a method for improving the freezing resistance and the thawing recovery rate of an embryo and a method for freezing an embryo. With the present invention, the freezing resistance and the thawing recovery rate of an embryo are significantly improved.

Abstract: The present disclosure relates to the field of early non-invasive diagnosis, and specifically, to a method of determining a virtual hepatic venous pressure gradient. The method includes: constructing a 3-dimensional (3D) hepatic vein-portal vein model; establishing a finite element division mathematical model; and applying fluid dynamics to compute and simulate a virtual hepatic venous pressure gradient (vHVPG). The method optimizes and improves a more complete 3D hepatic vein-portal vein model, finite element division, and fluid dynamic simulation computation, constructing and validating a new vHVPG determination technology providing better diagnosis, providing a safe, non-invasive, accurate, and quantitative method for early non-invasive diagnosis of a portal vein high pressure patient.

Abstract: The present invention belongs to the technical field of embryo cryopreservation. In particular, the present invention relates to an in-vitro embryonic culture medium for improving the thawed recovery rate of an embryo, comprising an inhibitor of Cathepsin L inhibitor, for example, E-64d. The present invention also relates to a method for improving the freezing resistance and the thawing recovery rate of an embryo and a method for freezing an embryo. With the present invention, the freezing resistance and the thawing recovery rate of an embryo are significantly improved.